Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

646
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
646
Primary Healthcare Services01:30

Primary Healthcare Services

1.5K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.5K
Drug Therapy01:28

Drug Therapy

93
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
93
Healthcare Agencies II01:17

Healthcare Agencies II

746
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
746
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

842
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
842
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

462
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
462

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-local free vibration spectra of nanostructures.

Nanotechnology·2026
Same author

Emergency department longitudinal integrated care (EDLINC) study: Protocol for a pragmatic effectiveness randomized clinical trial.

Contemporary clinical trials·2026
Same author

Patient-Centered Prescription Opioid Tapering Methods : A Randomized Clinical Trial.

Annals of internal medicine·2026
Same author

Using the Consolidated Framework for Implementation Research (CFIR) to explore mutual-help group implementation challenges in college recovery programs.

BMC health services research·2026
Same author

Integrating Large Language Models into Qualitative Methods in Health Services Research: A Proof-of-Concept Study.

Research square·2026
Same author

Patient Experiences With GLP-1 Receptor Agonists.

JAMA network open·2026

Related Experiment Video

Updated: Sep 4, 2025

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.3K

Addressing Methamphetamine Use in Primary Care: Provider Perspectives.

Julia Dunn1, Mina Yuan, Fernando Ramírez

  • 1From the Division of Public Mental Health and Population Sciences, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA (JD, MY, FR, HCG, MMG); Division of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine, Stanford, CA (CBJ, MMG); and Integrated Substance Abuse Programs, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA (HB, VPA, SL, RR).

Journal of Addiction Medicine
|July 16, 2022
PubMed
Summary

Primary care providers face challenges treating methamphetamine use due to a lack of standardized tools and FDA-approved medications. Enhanced support, including training and specialist connections, is needed to effectively manage stimulant use disorders.

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.8K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.3K

Related Experiment Videos

Last Updated: Sep 4, 2025

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.3K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.8K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.3K

Area of Science:

  • Addiction Medicine
  • Primary Care Practice
  • Public Health

Background:

  • The opioid epidemic has shifted towards a combined stimulant and opioid crisis, increasing overdose deaths.
  • Primary care providers are increasingly encountering patients with methamphetamine use disorder (MUD).
  • Current clinical practices for MUD in primary care are not well-understood, unlike established models for opioid use disorder.

Purpose of the Study:

  • To explore primary care providers' (PCPs) perceptions and practices regarding the identification and management of patients with methamphetamine use.
  • To identify barriers and facilitators to providing effective care for MUD in primary care settings.
  • To understand PCPs' perceived needs for improving services for patients with methamphetamine use.

Main Methods:

  • Conducted six semistructured group interviews with 38 primary care providers.
  • Focused interviews on provider experiences with patients exhibiting methamphetamine use.
  • Analyzed interview data using inductive and thematic analysis, categorizing findings by problem identification, clinical management, barriers/facilitators, and needs.

Main Results:

  • PCPs reported varied approaches to identifying and treating MUD, noting a lack of standardized screening tools and evidence-based treatments, especially medications.
  • Providers expressed a need for more standardized screening measures, FDA-approved medications, better connections to addiction specialists, and enhanced training.
  • There was notable interest in novel behavioral health interventions suitable for primary care.

Conclusions:

  • PCPs utilize diverse methods for MUD screening and treatment, but with limited perceived effectiveness.
  • Key challenges include the absence of FDA-approved medications, patient retention issues, referral difficulties, funding constraints, and inadequate training.
  • Harm reduction, motivational interviewing, and collaboration with addiction specialists are recommended strategies to support PCPs in managing patients with methamphetamine use.